Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) — Capital Reinvestment Ratio

Latest as of September 2024: 0.05x

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has a Capital Reinvestment Ratio of 0.05x as of September 2024, meaning it reinvests 0% of its operating cash flow ($753.12K) in capital expenditures ($41.04K). See HKPD net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$753.12K
USD

Capital Expenditures

$41.04K
USD

Data as of

Sep 2024
Most recent filing

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Capital Reinvestment Ratio (2023–2025)

This chart tracks Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Capital Reinvestment Ratio across 2 annual periods. Check Hong Kong Pharma Digital Technology Hold total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)

Year-by-year Capital Reinvestment Ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025. For live market cap and broader valuation context, see market value of Hong Kong Pharma Digital Technology Hold.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.27x $569.21K $154.99K ▲ +299.5%
2023 0.07x $1.73 Million $117.70K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow